alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2022185EN.01004601.xml

| 6.5.2022 | EN | Official Journal of the European Union | C 185/46 |
| --- | --- | --- | --- |

6.5.2022

EN

Official Journal of the European Union

C 185/46

---

Non-opposition to a notified concentration

(Case M.10691 – CDP GROUP / FOMAS GROUP / PUNCH GROUP / JV)

(Text with EEA relevance)

(2022/C 185/02)

On 2 May 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in Italian language and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10691. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10691. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
##### 



Exhibit 31.2 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Kevin G. Moug, certify that: 1.    I have reviewed this annual report on Form 10-K of Otter Tail
Corporation; 2.    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this report; 3.    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
report; 4.    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: (a)   designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared; (b)   evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; and (c)   disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal
quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrants internal
control over financial reporting; and 5.    The registrants other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions): (a)   all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and (b)   any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants
internal control over financial reporting. Date: March 12, 2004/s/ Kevin G. Moug
Kevin G. Moug
Chief Financial Officer and Treasurer
# C_2022272EN.01002501.xml

| 15.7.2022 | EN | Official Journal of the European Union | C 272/25 |
| --- | --- | --- | --- |

15.7.2022

EN

Official Journal of the European Union

C 272/25

---

Corrigendum to Communication from the Commission - Publication of the total number of allowances in circulation in 2021 for the purposes of the Market Stability Reserve under the EU Emissions Trading System established by Directive 2003/87/EC and of the number of unallocated allowances during the period 2013-2020

(
  Official Journal of the European Union C 195 of 13 May 2022
  )

(2022/C 272/06)

On page 5, in the fourth paragraph

for:

‘According to the reports from the auctions on the common auction platform and on the relevant opt-out platforms (14), the number of allowances auctioned between 1 January 2013 and 31 December 2021, including the so-called early auctions, is 6 598 419 287.’

read:

‘According to the reports from the auctions on the common auction platform and on the relevant opt-out platforms (14), the number of allowances auctioned between 1 January 2013 and 31 December 2021, including the so-called early auctions, is 6 591 205 500.’.

On page 5, in footnote 20

for:

‘See footnote 20 above.’

read:

‘See footnote 11.’.

On page 5, in footnote 21

for:

‘See footnote 21 above.’

read:

‘See footnote 11.’.

On page 6, in the third paragraph

for:

‘For the period up to 31 December 2021, there were therefore 2 632 682 071 allowances in the Reserve.’

read:

‘For the period up to 31 December 2021, there were therefore 2 632 682 062 allowances in the Reserve.’.

On page 6, in the table, row f), second column

for:

‘6 598 419 287’

read:

‘6 591 205 500’.

On page 7, in the table, row ‘Number of allowances in the Market Stability Reserve’, second column

for:

‘2 632 682 071’

read:

‘2 632 682 062’.

---
# C_2022136EN.01000101.xml

| 28.3.2022 | EN | Official Journal of the European Union | C 136/1 |
| --- | --- | --- | --- |

28.3.2022

EN

Official Journal of the European Union

C 136/1

---

Non-opposition to a notified concentration

(Case M.10597 – SMS / ALTOR FUND MANAGER / KAEFER HOLDING / KAEFER ISOLIERTECHNIK)

(Text with EEA relevance)

(2022/C 136/01)

On 18 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10597. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10597. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         September 19, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean C. Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on September 5, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail Express, Priority Mail & USPS Ground Advantage® Contract 298 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2024-618, CP2024-626.                

Sean C. Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-21311 Filed 9-18-24; 8:45 am]

BILLING CODE 7710-12-P
Exhibit 99

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549



FORM 11-K



[X]	ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the fiscal year ended September 30, 2003

OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934



Commission file number 2-82760



A.	Full title of the plan and address of the plan, if different from that of the issuer
	named below:

Peoples Energy Corporation
Employee Stock Purchase Plan



B.	Name of issuer of the securities held pursuant to the plan and the address of its
	principal executive office:

Peoples Energy Corporation
130 East Randolph Drive
Chicago, Illinois 60601





---



This Form 11-K is being filed for informational purposes only.



ITEM 1. An audited statement of financial condition as of the end of the latest two fiscal years of the plan.

Not applicable. Employees' payments for Company stock are neither segregated nor held for investment.

ITEM 2. An audited statement of income and changes in plan equity for each of the latest three fiscal years of the plan.

Not applicable. See above.





---



SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, Peoples Energy Corporation has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.



|                        |  | Peoples Energy Corporation  
|----------------------- |  | ----------------------------
|                        |  | Employee Stock Purchase Plan
|                        |  | (Name of Plan)              
|                        |  |                             
|Date: December 11, 2003 |  | By/s/ Thomas A. Nardi       
|                        |  | (Signature)                 
|                        |  | Thomas A. Nardi             
|                        |  | Senior Vice President and   
|                        |  | Chief Financial Officer     
|                        |  | Peoples Energy Corporation
<TABLE> <S> <C>


<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           1,024
<INT-BEARING-DEPOSITS>                           5,012
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    124,027
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         87,784
<ALLOWANCE>                                        500
<TOTAL-ASSETS>                                 227,211
<DEPOSITS>                                     148,621
<SHORT-TERM>                                    31,000
<LIABILITIES-OTHER>                            169,947
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            27
<OTHER-SE>                                      26,237
<TOTAL-LIABILITIES-AND-EQUITY>                 227,211
<INTEREST-LOAN>                                  1,657
<INTEREST-INVEST>                                2,265
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 3,922
<INTEREST-DEPOSIT>                               1,701
<INTEREST-EXPENSE>                               2,277
<INTEREST-INCOME-NET>                            1,645
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  1,143
<INCOME-PRETAX>                                    611
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       406
<EPS-BASIC>                                        .26
<EPS-DILUTED>                                      .26
<YIELD-ACTUAL>                                    3.30
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   500
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  500
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            500



</TABLE>
Docket No. FAA-2012-0188
# C_2022163EN.01000501.xml

| 19.4.2022 | EN | Official Journal of the European Union | C 163/5 |
| --- | --- | --- | --- |

19.4.2022

EN

Official Journal of the European Union

C 163/5

---

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)

(2022/C 163/05)

Decision granting an authorisation

| Reference of the decision (2) | Date of decision | Substance name | Holder of the authorisation | Authorisation number | Authorised use | Date of expiry of review period | Reasons for the decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| C(2022) 2191 | 11 April 2022 | 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
  (4-tert-OPnEO)
  EC No: -, CAS No:- | Hospira Zagreb d.o.o., a Pfizer company, Prudnicka cesta 60, 10291 Prigorje Brdovecko, Croatia | REACH/22/23/0 | As a surfactant in the manufacture of one biopharmaceutical protein, a biosimilar product, used to prevent infection and neutropenic fevers | 4 January 2033 | In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies |

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2022) 2191

11 April 2022

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated

(4-tert-OPnEO)

EC No: -, CAS No:-

Hospira Zagreb d.o.o., a Pfizer company, Prudnicka cesta 60, 10291 Prigorje Brdovecko, Croatia

REACH/22/23/0

As a surfactant in the manufacture of one biopharmaceutical protein, a biosimilar product, used to prevent infection and neutropenic fevers

4 January 2033

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies

---

(1)  OJ L 396, 30.12.2006 , p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu)

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
CAFETERIA OPERATORS, L.P. FINANCIAL STATEMENTS AS OF AND FOR THE PERIOD
ENDED JUNE 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-29-1998
<PERIOD-START>                             DEC-31-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                           7,927
<SECURITIES>                                         0
<RECEIVABLES>                                      867
<ALLOWANCES>                                        24
<INVENTORY>                                      5,964
<CURRENT-ASSETS>                                16,361
<PP&E>                                         103,666
<DEPRECIATION>                                  53,042
<TOTAL-ASSETS>                                  79,865
<CURRENT-LIABILITIES>                           27,200
<BONDS>                                         63,459
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    (23,795)
<TOTAL-LIABILITY-AND-EQUITY>                    79,865
<SALES>                                         94,244
<TOTAL-REVENUES>                                94,244
<CGS>                                           27,766
<TOTAL-COSTS>                                   27,766
<OTHER-EXPENSES>                                61,864
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 114
<INCOME-PRETAX>                                  4,500
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              4,500
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,500
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
# C_2022245EN.01000101.xml

| 28.6.2022 | EN | Official Journal of the European Union | C 245/1 |
| --- | --- | --- | --- |

28.6.2022

EN

Official Journal of the European Union

C 245/1

---

Non-opposition to a notified concentration

(Case M.10653 – ESTAVAYER LAIT / GIVAUDAN / BÜHLER / JV)

(Text with EEA relevance)

(2022/C 245/01)

On 16 June 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10653. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10653. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Order entered December 5, 2019

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-19-00710-CR

JOHN FRANCIS WALSH III, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the Criminal District Court No. 2

Dallas County, Texas

Trial Court Cause No. F17-75832-H

ORDER

Before the Court is appellant’s December 3, 2019 second motion for extension of time to 

file his brief. We GRANT the motion and ORDER appellant’s brief due on or before January 6, 

2020. Appellant is cautioned that the failure to file a brief by that date may result in the appeal 

being abated for a hearing under rule 38. See TEX. R. APP. P. 38.8(b)(3).

/s/ CORY L. CARLYLE 

JUSTICE
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-18-00257-CV

IN RE HULCHER SERVICES, INC.,

Relator

§

§

§

§

§

Original Proceeding

From the 236th District Court

of Tarrant County (236-228956-08)

October 11, 2018

Opinion by Justice Birdwell

JUDGMENT

This court has considered the petition for writ of mandamus filed by relator 

Hulcher Services, Inc. We conditionally grant relator’s petition. Writ will issue only if 

the trial court fails to vacate the July 27, 2018 order striking Hulcher’s jury demand

and requiring that “the issue of attorney’s fees be held to the court.”

It is further ordered that real party in interest Emmert Industrial Corp. shall 

pay all costs of this proceeding, for which let execution issue.

SECOND DISTRICT COURT OF APPEALS 

By _/s/ Wade Birdwell___________________

 Justice Wade Birdwell